How should you manage patients who discontinue Sublocade?
•
6 min read
Due to its extended-release formulation, Sublocade creates a natural, gradual tapering effect after the last injection, releasing therapeutic levels of buprenorphine for months. This unique pharmacological profile significantly influences how you manage patients who discontinue Sublocade, necessitating a focus on long-term monitoring and robust supportive care.
